Merck CEO Kenneth Frazier will remain at the helm of the pharmaceutical company after its board of directors rescinded a policy that required the chief executive to retire at the age of 65, according ...
Belén Garijo, who steered Merck KGaA through the COVID-19 pandemic, will step down as CEO of the German healthcare and electronics conglomerate. Garijo will end her five-year tenure as planned by the ...
Over on Fox Business Network this morning, Stuart Varney criticized Merck CEO Kenneth Frazier for his decision to step down from the White House’s American Manufacturing Council. In his statement, ...
Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst ...
Hosted on MSN
Merck & Co., Inc. (MRK)’s CEO Thinks He’s Got $50 Billion Of New Drugs, Says Jim Cramer
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback